 |
Nearly 50 years ago scientists discovered that detonating powerful explosives had the ability to create, not just destroy. Nanodiamonds, diamond-structured particles measuring less than 10 nanometers in diameter, which are the resultant residue from a TNT or Hexogen explosion in a contained space, are now being studied in a variety of science, technology and health applications. A team of researchers who specialize in nanotechnology, led by Dr. Yury Gogotsi, director of the A.J. Drexel Nanotechnology Institute, offered a review of nanodiamond research, in the December 18 edition of Nature Nanotechnology to sift through new ways scientists are using these tiny treasures.
On the figure: Structure of a single nanodiamond particle
The authors, who also include Dr. Vadym Mochalin, assistant research professor of materials science at Drexel, Dr. Olga Shenderova senior scientist and head of the Nanodiamond Laboratory at the International Technology Center (ITC) and Dr. Dean Ho, associate professor of biomedical and mechanical engineering at Northwestern University, survey a rapidly growing field of fundamental and applied research as well as technological development surrounding nanodiamonds.
“We examine the importance of nanodiamond in biomedical, optical, composites, lubricants and other applications,” Gogosti said. “The success of nanodiamond materials in biomedical applications stems from the fact that many small molecules such as proteins, antibodies, therapeutics and nucleic acids can bind to the surface of nanodiamonds, making it an ideal candidate for use in drug-delivery and surgical implants.”
According to the piece, nanodiamonds possess a unique combination of qualities, such as accessible surface area, versatile chemistry, chemical stability and biocompatibility. These traits, and the fact that nanodiamonds are non-toxic, make the particles ideal candidates for a variety of tasks including drug delivery cancer diagnostics, and mimicking proteins.
“Rich and very versatile surface chemistry, which can be and, actually, needs to be tailored for each particular application of nanodiamond, makes possible matching this material to a variety of environments, ranging from oil to water and polymers,” Mochalin said. “This is especially important when considering nanodiamond’s application in drug delivery and polymer composites for tissue engineering scaffolds.”
Specific uses mentioned in the group’s survey of the research include using nanodiamonds for targeted therapy and imaging, two applications essential to the treatment of cancer. The article notes that preliminary studies in mice have shown that drugs mediated with nanodiamond were able to reduce a tumor’s ability to resist the drug treatment.
Here we demonstrate a new developed method for depositing Ti3C2Tx MXenes onto hydrophobic electrospun PCL membranes using oxygen plasma treatment. These novel patches hold tremendous potential for providing mechanical support to damaged heart tissue and enabling electrical signal transmission,thereby mimicking the crucial electroconductivity required for normal cardiac function. After a detailed investigation of scaffold-to-cell interplay, including electrical stimulation, novel technology has the potential for clinical application not only for cardiac regeneration, but also as neural and muscular tissue substitutes.
MX-MAP project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed split secondment visit to project partner organization University of Padova (Italy). MX-MAP project works on development of the key strategies for MXene medical applications. 
CanbioSe Project Meeting and Project Workshop was held at European Institute of Membranes (IEM), University of Montpellier, France on September 26-27, 2023. The workshop was focused on the theme of "Commercializing Biosensors, Intellectual Property, and Knowledge Transfer from Academia to Industry.
Dr. Oleksiy Gogotsi and Veronika Zahorodna visited IEEE NAP 2023 conference held in Bratislava on September 10-15, 2023. The prime focus of the IEEE NAP-2023 was on nanoscale materials with emphasis on interdisciplinary research exploring and exploiting their unique physical and chemical proprieties for practical applications.
Director of MRC and Carbon-Ukraine Dr. Oleksiy Gogotsi visited CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA). He meet with Dr. Pierluigi Bilotto, Dr. Chriatian Pichler and their colleagues, discussing novel materials and r&d activities for new technologies.
MX-MAP Session was held during the YUCOMAT Conference 2023 titled: "Towards MXenes’ biomedical applications by high-dimensional immune MAPping", HORIZON-MSCA-2021-SE-01 project MX-MAP.
CANBIOSE project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed secondment visit to project partner organization European Institute of Membranes in Montpellier (France) on August -September 2023.
MRC researchers Dr. Oleksiy Gogotsi and Veronika Zahorodna were visiting Nanobiomedical Centre, Adam Mickewicz University in Poznan, Poland due to close collaboration with AMU team led by Dr. Igor Iatsunskiy. 
Meeting during the MXene international conference held in Drexel University on Aug. 3, 2022, and discussing the roadmap for launching MX-MAP research project on MXenes for medical applications.